RxDataLab

Most biotech intelligence is repackaged press releases and analyst commentary. These are sources where the marketers at the company control the narrative, and only the loud companies have narratives. RxDataLab works from the other direction.

We pull from ClinicalTrials.gov, SEC EDGAR, USPTO patent records, and financial market data. The disclosures and filings that get made because they have to be, not because someone hired a PR team. We then harmonize the data, validate it, and link it together. What companies actually do often looks different from what they say, and that’s what we track.

This comes from nearly 10 years of building data pipelines for biotech and research institutions — the same systematic infrastructure work, now pointed at public regulatory data and made useful for BD, investors, and strategy teams.

What We Cover

Our focus is intentionally limited in scope and disciplined. We only track companies with active registrations on ClinicalTrials.gov and mandated US regulatory filings. If a program hasn’t reached the clinical registry, it hasn’t crossed our threshold for monitoring. We are not a retail catalyst tracker or news aggregator, and we do not do stock picks. RxDataLab is a curated primary-source database. We are constantly working to improve and create new high-value data sets for the business of biotech.

Biotech intelligence platform — Company views with daily updates, automatic change detection, and SEC and market data linked to clinical programs. 450K+ trials and 500+ public companies.

Custom intelligence and due diligence — Deep-dive competitive assessments and technical program reviews for specific companies or therapeutic areas.

Data products — Structured datasets for specific workflows: exclusivity tracking, pipeline mapping, and filing analysis. We can also design custom data feeds and API’s for your team that work well will AI tools like Claude, Gemini, or ChatGPT. Reach out with questions.

Guides and research — The analytical methods and primary source workflows behind all of it.

Methodology & Transparency — We believe in audit-able “Proof of Work.” We document our data harmonization processes, from ML and LLM-based entity resolution to linking SEC EDGAR to NCT IDs. Our users can trust and verify the provenance of every data point.